Abstract: Disclosed is a pharmaceutical composition, comprising metronidazole or a pharmaceutically acceptable salt thereof, sucrose acetate isobutyrate (SAIB), and ethyl acetate. Also disclosed is a method treating or preventing a protozoal or bacterial infection or disease, comprising administering to a non-human subject in need thereof a therapeutically effective amount of the pharmaceutical composition.

Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.

Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.

Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.

Abstract: The present invention relates to compositions comprising spicamycin derivatives, methods of making such compositions, and their use in the treatment and/or prevention of pain, including neuropathic pain.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10?6 to 100 mg/ml.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1–4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10?6 to 100 mg/ml.

Abstract: A method for testing the breath alcohol (ethanol) content with an embedded PC computer with a touch screen display uses software graphics with icons and graphs displaying an instant representation of the flow rate and breath alcohol concentration of the breath being delivered by the person taking the test. A software graphics using icons and graphs provides control panels by which a test administrator or technician is able to control fundamental operations and adjustments of the instrument. A geared, stepped, multiple optical component placement system having dual plates retains these components, and is capable of precision placement of all components using one electro-mechanical device. An infrared optical filter system operates between 3 and 10 microns. The results are stored in memory and are capable of comparisons to empirical tables for chemical identification.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10-6 to 100 mg/ml.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.

Abstract: A composition is provided for treating diseased, injured or diseased cartilage comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at the site for a period of time sufficient to alleviate the symptoms of the disease, injury or abnormality. Preferably hyaluronic acid is used in a composition range of 0.01-4% by weight and the preferred growth factor is IGF-I, present in a concentration range of about 10−6 to 100 mg/ml.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.

Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at the site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10.sup.-6 to 100 mg/ml.

Abstract: An improved panel mounting assembly for a vehicle antenna mast wherein the assembly is provided with an anchoring arrangement which eliminates the need for stamping a raised stiffening dimple in the panel design surface contour. A mounting assembly mast tubular holding section, which extends vertically through a panel aperture, is provided with a downwardly extending support tube uniquely coupled to and forming a part of the section lower end. The support tube is held in a subjacent body frame member opening by a snap-fitted rubber grommet permitting limited reciprocal travel of the support tube. The arrangement accommodates vehicle build tolerances between the panel and frame during assembly, while stabilizing the antenna structure against fore, aft and lateral movement relative to the panel.